ALPHA KETOZOX DS

MRP

MRP 800/-STRIP

Description

• Each film coated tablet contains: Calcium-3-methyl-2-oxo-valerate 134mg  (a-ketoanalogue to isoleucine, calcium salt) + Calcium-4-methyl-2-oxo-valerate 202mg (a-ketoanalogue to leucine, calcium salt) + Calcium-2-oxo-3 phenylpropionate 136mg + (a-ketoanalogue to Phenylalanine, calcium salt) + Calcium-3-methyl-2-oxo butyrate 172mg  + (a-ketoanalogue to valine, calcium salt) + Calcium-DL-2-hydroxy-4-(methylthio) butyrate 118mg (a-hydroxyanalogue to methionine, calcium salt) + Lysine-acetate USP  210mg + (Eq. to L-Lysine 150mg) + L-Threonine IP 106mg L-Tryptophan IP 46mg + Histidine Hydrochloride Monohydrate   BP  Eq. to Histidine  76mg  + L-Tyrosine USP   60mg  + Total Nitrogen content per tablet 72mg  Total Calcium content per tablet (2.50m mol = 0.1gm)  Excipients   q.s.

Doses

• As directed by the Physician

Indication

• ALPHA KETOANALOGUE is used in the treatment of chronic kidney disease. ALPHA KETOANALOGUE contains “Alpha Ketoanalogue”, and it works by prevents the unnecessary increase in urea levels in the blood due to the intake of non-essential amino acids in patients of kidney failure. Thereby improving renal function.